Suppr超能文献

《生存指南》,2017年第2版,美国国立综合癌症网络(NCCN)肿瘤临床实践指南

Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

作者信息

Denlinger Crystal S, Sanft Tara, Baker K Scott, Baxi Shrujal, Broderick Gregory, Demark-Wahnefried Wendy, Friedman Debra L, Goldman Mindy, Hudson Melissa, Khakpour Nazanin, King Allison, Koura Divya, Kvale Elizabeth, Lally Robin M, Langbaum Terry S, Melisko Michelle, Montoya Jose G, Mooney Kathi, Moslehi Javid J, O'Connor Tracey, Overholser Linda, Paskett Electra D, Peppercorn Jeffrey, Rodriguez M Alma, Ruddy Kathryn J, Silverman Paula, Smith Sophia, Syrjala Karen L, Tevaarwerk Amye, Urba Susan G, Wakabayashi Mark T, Zee Phyllis, Freedman-Cass Deborah A, McMillian Nicole R

出版信息

J Natl Compr Canc Netw. 2017 Sep;15(9):1140-1163. doi: 10.6004/jnccn.2017.0146.

Abstract

Many cancer survivors experience menopausal symptoms, including female survivors taking aromatase inhibitors or with a history of oophorectomy or chemotherapy, and male survivors who received or are receiving androgen-ablative therapies. Sexual dysfunction is also common in cancer survivors. Sexual dysfunction and menopause-related symptoms can increase distress and have a significant negative impact on quality of life. This portion of the NCCN Guidelines for Survivorship provide recommendations for screening, evaluation, and treatment of sexual dysfunction and menopausal symptoms to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period.

摘要

许多癌症幸存者会经历更年期症状,包括服用芳香化酶抑制剂或有卵巢切除术或化疗史的女性幸存者,以及接受或正在接受雄激素剥夺疗法的男性幸存者。性功能障碍在癌症幸存者中也很常见。性功能障碍和更年期相关症状会增加痛苦,并对生活质量产生重大负面影响。《NCCN生存指南》的这一部分提供了关于性功能障碍和更年期症状的筛查、评估和治疗的建议,以帮助在治疗后阶段与成年期癌症幸存者打交道的医疗保健专业人员。

相似文献

1
Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2017 Sep;15(9):1140-1163. doi: 10.6004/jnccn.2017.0146.
2
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2018 Oct;16(10):1216-1247. doi: 10.6004/jnccn.2018.0078.
3
NCCN Guidelines Insights: Survivorship, Version 1.2016.
J Natl Compr Canc Netw. 2016 Jun;14(6):715-24. doi: 10.6004/jnccn.2016.0073.
4
NCCN Guidelines® Insights: Survivorship, Version 1.2022.
J Natl Compr Canc Netw. 2022 Oct;20(10):1080-1090. doi: 10.6004/jnccn.2022.0052.
5
NCCN Guidelines Insights: Survivorship, Version 2.2020.
J Natl Compr Canc Netw. 2020 Aug;18(8):1016-1023. doi: 10.6004/jnccn.2020.0037.
6
NCCN Guidelines® Insights: Survivorship, Version 1.2023.
J Natl Compr Canc Netw. 2023 Aug;21(8):792-803. doi: 10.6004/jnccn.2023.0041.
7
Survivorship: introduction and definition. Clinical practice guidelines in oncology.
J Natl Compr Canc Netw. 2014 Jan;12(1):34-45. doi: 10.6004/jnccn.2014.0005.
8
NCCN Guidelines Insights: Survivorship, Version 2.2019.
J Natl Compr Canc Netw. 2019 Jul 1;17(7):784-794. doi: 10.6004/jnccn.2019.0034.
9
Sexual Function in Cancer Survivors: Updates to the NCCN Guidelines for Survivorship.
J Natl Compr Canc Netw. 2016 May;14(5 Suppl):685-9. doi: 10.6004/jnccn.2016.0193.
10
Survivorship, Version 1.2021.
J Natl Compr Canc Netw. 2021 Jun 30;19(6):676-685. doi: 10.6004/jnccn.2021.0028.

引用本文的文献

1
Molecular characterization and antibiotic susceptibility of methicillin-resistant in immunocompromised cancer patients.
Int J Immunopathol Pharmacol. 2025 Jan-Dec;39:3946320251352258. doi: 10.1177/03946320251352258. Epub 2025 Aug 25.
5
Breast cancer patients' experience of menopause care in the UK: thematic analysis of free-text comments.
Menopause. 2025 May 1;32(5):409-419. doi: 10.1097/GME.0000000000002505.
6
Patient experience of menopause care after breast cancer in the UK: a cross-sectional study.
Menopause. 2025 May 1;32(5):396-408. doi: 10.1097/GME.0000000000002504.
8
Sleep disturbances based on patient reported outcomes in patients with breast cancer.
Sleep Breath. 2024 Dec;28(6):2491-2500. doi: 10.1007/s11325-024-03150-w. Epub 2024 Sep 3.

本文引用的文献

1
Comparison of intravaginal 6.5mg (0.50%) prasterone, 0.3mg conjugated estrogens and 10μg estradiol on symptoms of vulvovaginal atrophy.
J Steroid Biochem Mol Biol. 2017 Nov;174:1-8. doi: 10.1016/j.jsbmb.2017.03.014. Epub 2017 Mar 18.
4
Long-term hormone therapy for perimenopausal and postmenopausal women.
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
5
Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.
Mayo Clin Proc. 2017 Jan;92(1):114-128. doi: 10.1016/j.mayocp.2016.09.018. Epub 2016 Dec 1.
7
Patient-provider communication about sexual concerns in cancer: a systematic review.
J Cancer Surviv. 2017 Apr;11(2):175-188. doi: 10.1007/s11764-016-0577-9. Epub 2016 Nov 17.
8
Mind-body interventions for vasomotor symptoms in healthy menopausal women and breast cancer survivors. A systematic review.
J Psychosom Obstet Gynaecol. 2017 Sep;38(3):210-225. doi: 10.1080/0167482X.2016.1235147. Epub 2016 Nov 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验